Opin vísindi

Fletta eftir efnisorði "Biomarkers"

Fletta eftir efnisorði "Biomarkers"

Röðun: Raða: Niðurstöður:

  • Icon
    Potential Health Risk of Endocrine Disruptors in Construction Sector and Plastics Industry: A New Paradigm in Occupational Health 
    Fucic, Aleksandra; Galea, Karen; Duca, Radu; El Yamani, Mounia; Frery, Nadine; Godderis, Lode; Halldorsson, Thorhallur; Iavicoli, Ivo; Ndaw, Sophie; Ribeiro, Edna; Viegas, Susana; Moshammer, Hanns (MDPI AG, 2018-06-11)
    Endocrine disruptors (EDs) belong to large and diverse groups of agents that may cause multiple biological effects associated with, for example, hormone imbalance and infertility, chronic diseases such as diabetes, genome damage and cancer. The health ...
  • Icon
    Predicting the probability of death using proteomics 
    Eiriksdottir, Thjodbjorg; Ardal, Steinthor; Jonsson, Benedikt A.; Lund, Sigrun H.; Ivarsdottir, Erna V.; Norland, Kristjan; Ferkingstad, Egil; Stefansson, Hreinn; Jónsdóttir, Ingileif; Holm, Hilma; Rafnar, Thorunn; Saemundsdottir, Jona; Norddahl, Gudmundur L.; Þorgeirsson, Guðmundur; Gudbjartsson, Daniel F.; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari; Úlfarsson, Magnús Örn (2021-06-18)
    Predicting all-cause mortality risk is challenging and requires extensive medical data. Recently, large-scale proteomics datasets have proven useful for predicting health-related outcomes. Here, we use measurements of levels of 4,684 plasma proteins ...
  • Icon
    Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects 
    Jónsson, Steinn; Franklin, Wilbur A.; Varella-Garcia, Marileila; Kennedy, Timothy C.; Merrick, Daniel; Matney, Kathryn D.; Oskarsdottir, Gudrun N.; Saemundsson, Arni; Keith, Robert L.; Bunn, Paul A.; Miller, York E. (2023-10)
    Bronchial squamous carcinoma in situ (CIS) is a preinvasive lesion that is thought to precede invasive carcinoma. We conducted prospective autofluorescence and white light bronchoscopy trials between 1992 and 2016 to assess the prevalence, molecular ...
  • Icon
    Sequence variants associating with urinary biomarkers 
    Benonisdottir, Stefania; Kristjansson, Ragnar P; Oddsson, Asmundur; Steinthorsdottir, Valgerdur; Mikaelsdottir, Evgenia; Kehr, Birte; Jensson, Brynjar O; Arnadottir, Gudny A; Sulem, Gerald; Sveinbjornsson, Gardar; Kristmundsdóttir, Snædís; Ívarsdóttir, Erna V.; Tragante, Vinicius; Gunnarsson, Bjarni; Runolfsdottir, Hrafnhildur Linnet; Arthur, Joseph G; Deaton, Aimee M; Eyjolfsson, Gudmundur I; Davidsson, Olafur B; Asselbergs, Folkert W; Hreidarsson, Astradur B; Rafnar, Thorunn; Thorleifsson, Gudmar; Edvardsson, Vidar; Sigurdsson, Gunnar; Helgadottir, Anna; Halldórsson, Bjarni; Masson, Gisli; Holm, Hilma; Önundarson, Páll Torfi; Indridason, Olafur S; Benediktsson, Rafn; Palsson, Runolfur; Gudbjartsson, Daniel F; Olafsson, Isleifur; Thorsteinsdottir, Unnur; sulem, patrick; Stefansson, Kari (Oxford University Press (OUP), 2018-11-24)
    Urine dipstick tests are widely used in routine medical care to diagnose kidney and urinary tract and metabolic diseases. Several environmental factors are known to affect the test results, whereas the effects of genetic diversity are largely unknown. ...
  • Icon
    Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans 
    Ravindra, Kodihalli C; Vaidya, Vishal S; Wang, Zhenyu; Federspiel, Joel D; Virgen-Slane, Richard; Everley, Robert A; Grove, Jane I; Stephens, Camilla; Ocana, Mireia F; Robles-Díaz, Mercedes; Isabel Lucena, M; Andrade, Raul J; Atallah, Edmond; Gerbes, Alexander L; Weber, Sabine; Cortez-Pinto, Helena; Fowell, Andrew J; Hussaini, Hyder; Björnsson, Einar Stefán; Patel, Janisha; Stirnimann, Guido; Verma, Sumita; Elsharkawy, Ahmed M; Griffiths, William J H; Hyde, Craig; Dear, James W; Aithal, Guruprasad P; Ramaiah, Shashi K (2023-03-03)
    Diagnosis of drug-induced liver injury (DILI) and its distinction from other liver diseases are significant challenges in drug development and clinical practice. Here, we identify, confirm, and replicate the biomarker performance characteristics of ...
  • Icon
    Towards defining biomarkers to evaluate concussions using virtual reality and a moving platform (BioVRSea) 
    Jacob, Deborah Cecelia Rose; Unnsteinsdóttir Kristensen, Ingunn S.; Aubonnet, Romain; Recenti, Marco; Donisi, Leandro; Ricciardi, Carlo; Svansson, Halldór Á.R.; Agnarsdóttir, Sólveig; Colacino, Andrea; Jónsdóttir, María Kristín; Kristjánsdóttir, Hafrún; Sigurjónsdóttir, Helga Ágústa; Cesarelli, Mario; Claessen, Lára Ósk Eggertsdóttir; Hassan, Mahmoud; Petersen, Hannes; Gargiulo, Paolo (2022-05-30)
    Current diagnosis of concussion relies on self-reported symptoms and medical records rather than objective biomarkers. This work uses a novel measurement setup called BioVRSea to quantify concussion status. The paradigm is based on brain and muscle ...
  • Icon
    Towards neurophysiological biomarkers to assess repetitive transcranial magnetic stimulation treatment for patients with schizophrenia and auditory verbal hallucinations 
    Banea, Ovidiu Constantin (2022-01)
    Background: Repetitive transcranial magnetic stimulation (RTMS) has been suggested as a possible therapeutic alternative for patients with schizophrenia (SCZ) and treatment-resistant auditory verbal hallucinations (AVH). The aim of the studies presented ...
  • Icon
    Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis : a combined analysis of multiple studies 
    Curtis, Jeffrey R.; Weinblatt, Michael E.; Shadick, Nancy A.; Brahe, Cecilie H.; Østergaard, Mikkel; Hetland, Merete Lund; Sævarsdóttir, Sædís; Horton, Megan; Mabey, Brent; Flake, Darl D.; Ben-Shachar, Rotem; Sasso, Eric H.; Huizinga, T. W. (2021-01-04)
    BACKGROUND: The multi-biomarker disease activity (MBDA) test measures 12 serum protein biomarkers to quantify disease activity in RA patients. A newer version of the MBDA score, adjusted for age, sex, and adiposity, has been validated in two cohorts ...